India's Midcap Premium Is Now Earned Stock by Stock
420 words

India's Midcap Premium Is Now Earned Stock by Stock
Two listed hospital groups, same country, same quarter, same regulatory framework, two unrelated results. Apollo Hospitals reported on 12 August revenue up 21% and net profit of ₹581 crore, up 34% 1. Max Healthcare reported the following day revenue up 16.7%, at ₹2,366 crore, but net profit of ₹323 crore against ₹308 crore a year earlier, a gain of 4.9% 2. Both grew their top line at a comparable pace. Only one converted it into profit.
Margin is where the gap opens. At Max Healthcare, net margin fell back to 13.6%, against 15.2% a year earlier and 16.0% in the previous quarter 2. Apollo's earnings before interest, tax, depreciation and amortisation rose 28%, faster than its revenue; Max Healthcare's rose 14.4%, slower than its own 12. The phenomenon extends beyond healthcare: over the same period Shriram Finance posted net profit up nearly 60% 3 and TVS Motor up 51% 4. Within a single capitalisation band, those rates were far more tightly clustered in previous quarters. The common thread is not weakness: revenue and profit are both rising strongly almost everywhere. TVS Motor even raised prices across nearly its entire range on 1 August while posting its best sales month on record, a sign of pricing power rather than a volume effect 5.
The objection concerns perspective: high dispersion in a single quarter may reflect base effects and capacity-opening schedules rather than a lasting divergence in quality. It is admissible for the hospitals, where bed commissioning mechanically shifts margins. It explains less well why a lender and a manufacturer show comparable gaps at the same moment.
The bottom line
Exposure to Indian midcaps is built stock by stock. Index exposure today buys the average of a set whose components are diverging sharply, which dilutes precisely the selectivity investors come for.
What to watch: dispersion in the following quarter. If it persists, selection becomes the determining factor in returns. If it narrows, the first quarter will have reflected nothing more than staggered investment schedules.
Sources(5 sources)
- [1]Indian Pharma Post — "Apollo Hospitals posts 21% revenue growth in Q1 FY27"
- [2]Investing.com — "Max Healthcare Q1 FY27 slides: revenue jumps 16% amid expansion"
- [3]Business Standard — "Shriram Finance's Q1 FY27 profit jumps 60% on strong NII, AUM growth"
- [4]Business Standard — "TVS Motor reports 38% YoY sales growth in July 2026"
